冠状动脉CT血管造影诊断血管痉挛性心绞痛:与侵入性冠状动脉造影及麦角新碱激发试验的比较
本研究纳入33例(75处病变)血管痉挛性心绞痛患者,比较冠状动脉CT血管造影(cCTA)与侵入性冠状动脉造影联合麦角新碱激发试验(iCAG-EPT)的诊断效能,发现cCTA诊断显著痉挛的敏感度仅7.5%、特异度94.0%、准确率48.0%,舌下含服硝酸甘油者Δ%DS更高(39.2% vs. 22.1%,p=0.002),作者认为不能仅凭cCTA结果排除血管痉挛性心绞痛,需考虑iCAG-EPT确认。
要点
- cCTA诊断血管痉挛性心绞痛的敏感度低(7.5%),不能仅凭cCTA阴性排除诊断。
- cCTA诊断显著痉挛的特异度94.0%、准确率48.0%,阳性预测值60.0%。
- 舌下含服硝酸甘油者痉挛严重程度差值更大(39.2% vs. 22.1%,p=0.002)。
核心结论
- 对临床疑似血管痉挛性心绞痛的患者,不能仅凭cCTA结果排除诊断,需考虑iCAG-EPT确认;尚需进一步前瞻性研究证实。
研究设计与样本
- 回顾性纳入2006年至2016年诊断为血管痉挛性心绞痛的1397例患者中33例(75处病变),均在iCAG-EPT前6个月内可行cCTA;以iCAG-EPT为参考标准,评估cCTA诊断显著痉挛的效能。
关键影像表现/征象
- cCTA与iCAG-EPT的痉挛严重程度差值(Δ%DS)在舌下含服硝酸甘油组为39.2%,未含服组为22.1%(p=0.002)。
- β受体阻滞剂治疗组与未治疗组的Δ%DS无差异(35.1% vs. 32.6%,p=0.643)。
- 舌下含服硝酸甘油相关的Δ%DS差异在年龄<60岁、男性、体质指数<25 kg/m²、无高血压/糖尿病/血脂异常病史者中更明显。
诊断标准与关键数值
- 以iCAG-EPT为参考,cCTA诊断血管痉挛性心绞痛的基于病变的敏感度7.5%、特异度94.0%、阳性预测值60.0%、阴性预测值47.1%、准确率48.0%。
- iCAG-EPT或cCTA上%DS≥50%定义为显著痉挛。
临床应用与阅片要点
- 阅读cCTA时,对临床疑似血管痉挛性心绞痛患者,阴性结果不能排除诊断,需建议iCAG-EPT确认。
- 注意cCTA检查前是否舌下含服硝酸甘油,可能影响痉挛严重程度的评估。
局限性
- 原文结论指出尚需进一步前瞻性研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the diagnostic validity of coronary computed tomography angiography (cCTA) in vasospastic angina (VA) and factors associated with discrepant results between invasive coronary angiography with the ergonovine provocation test (iCAG-EPT) and cCTA.
MATERIALS AND METHODS: Of the 1397 patients diagnosed with VA from 2006 to 2016, 33 patients (75 lesions) with available cCTA data from within 6 months before iCAG-EPT were included. The severity of spasm (% diameter stenosis [%DS]) on iCAG-EPT and cCTA was assessed, and the difference in %DS (Δ%DS) was calculated. Δ%DS was compared after classifying the lesions according to pre-cCTA-administered sublingual nitroglycerin (SL-NG) or beta-blockers. The lesions were further categorized with %DS ≥ 50% on iCAG-EPT or cCTA defined as a significant spasm, and the diagnostic performance of cCTA on identifying significant spasm relative to iCAG-EPT was assessed.
RESULTS: Compared to lesions without SL-NG treatment, those with SL-NG treatment showed a higher Δ%DS (39.2% vs. 22.1%, p = 0.002). However, there was no difference in Δ%DS with or without beta-blocker treatment (35.1% vs. 32.6%, p = 0.643). The significant difference in Δ%DS associated with SL-NG was more prominent in patients who were aged < 60 years, were male, had body mass index < 25 kg/m², and had no history of hypertension, diabetes, or dyslipidemia. Based on iCAG-EPT as the reference, the per-lesion-based sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of cCTA for VA diagnosis were 7.5%, 94.0%, 60.0%, 47.1%, and 48.0%, respectively.
CONCLUSION: For patients with clinically suspected VA, confirmation with iCAG-EPT needs to be considered without completely excluding the diagnosis of VA simply based on cCTA results, although further prospective studies are required for confirmation.
引用
- Park J, Kim HK, Park EA, et al. Coronary Computed Tomography Angiography for the Diagnosis of Vasospastic Angina: Comparison with Invasive Coronary Angiography and Ergonovine Provocation Test. Korean J Radiol. 2019. PMID: 30993923. doi:10.3348/kjr.2018.0847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。